Metraipolis › archive › dc_c660eb092a6b
mRNA Multipeptide-HLA Class II Immunotherapy for Melanoma — Europe PMC PMID:41002395
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41002395
- DOI
- 10.3390/cells14181430
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T23:40:25.402Z
- SHA-256 of the archived text
a942532f127e69955b1e6128405188601efa1278b0eef149e48bd2600c788492- Stable URL of this page
https://metraipolis.com/documento/dc_c660eb092a6b
How to cite
mRNA Multipeptide-HLA Class II Immunotherapy for Melanoma — Europe PMC PMID:41002395 — Europe PMC (en), https://europepmc.org/article/MED/41002395 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c660eb092a6b (Metraipolis archive dc_c660eb092a6b, sha256 a942532f127e69955b1e6128405188601efa1278b0eef149e48bd2600c788492)
BibTeX
@misc{dcc660eb092a6b,
title = {mRNA Multipeptide-HLA Class II Immunotherapy for Melanoma — Europe PMC PMID:41002395},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41002395},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c660eb092a6b; sha256 a942532f127e69955b1e6128405188601efa1278b0eef149e48bd2600c788492},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41002395. Agents can read the archived copy with the MCP tool read_document.